dc.contributorFaculdade de Medicina de Marília (FAMEMA)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:19:37Z
dc.date.accessioned2022-10-05T17:37:09Z
dc.date.available2014-05-27T11:19:37Z
dc.date.available2022-10-05T17:37:09Z
dc.date.created2014-05-27T11:19:37Z
dc.date.issued1998-10-08
dc.identifierVeterinary and Human Toxicology, v. 40, n. 5, p. 257-259, 1998.
dc.identifier0145-6296
dc.identifierhttp://hdl.handle.net/11449/65530
dc.identifierWOS:000075969300001
dc.identifier2-s2.0-0031693181
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3915448
dc.description.abstractMagnesium chloride (MgCl2) has been proposed for the treatment of seizures of different etiologies. The present study investigated the effect of MgCl2 on aldrin-induced seizures. Initially, 50 male rats received 60 mg aldrin/kg po and the effects were classified as muscular twitches, clonic convulsions or tonic-clonic convulsions. Another group of 40 rats dosed with 60 mg aldrin/kg po received 0, 4, 8, or 12 mg MgCl2/kg im. The percentage of tonic-clonic convulsant rats that resulted from MgCl2 treatment were 90% at 0 mg/kg; 50% at 4 mg/kg, 40% at 8 mg/kg and 20% at 12 mg MgCl2/kg. The percentage of survivors in the group receiving 12 mg MgCl2/kg was 80% while the control group had 20% survival. The clonic convulsions were not modified by MgCl2 treatment. Blood and brain concentrations of aldrin and dieldrin (metabolite of aldrin) did not differ among groups. The MgCl2 administration decreased the neuroexcitability induced by aldrin and increased survivability.
dc.languageeng
dc.relationVeterinary and Human Toxicology
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectaldrin
dc.subjectmagnesium chloride
dc.subjectanimal experiment
dc.subjectanticonvulsant therapy
dc.subjectbrain level
dc.subjectcontrolled study
dc.subjectdrug effect
dc.subjectmale
dc.subjectneurotoxicity
dc.subjectnonhuman
dc.subjectrat
dc.subjectseizure
dc.subjectAldrin
dc.subjectAnimals
dc.subjectBehavior, Animal
dc.subjectDrug Interactions
dc.subjectInsecticides
dc.subjectMagnesium Chloride
dc.subjectMale
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectSeizures
dc.subjectAnimalia
dc.titleDoes magnesium chloride modify aldrin-induced neurotoxicity in rats?
dc.typeArtigo


Este ítem pertenece a la siguiente institución